<div class="entities" style="line-height: 2.5; direction: ltr">Admission Date:  [**2159-4-21**]              Discharge Date:   [**2159-5-15**]<br><br>Date of Birth:  [**2083-5-13**]             Sex:   M<br><br>Service: MEDICINE<br><br>Allergies:<br>Patient recorded as having No Known Allergies to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Drugs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>Attending:[**First Name3 (LF) 2071**]<br>Chief Complaint:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fatigue
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 for one week. Transferred to CCU with hypoxic distress<br>in context of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    AF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    with
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RVR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, developed PNA and transferred to MICU<br>with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stabilized
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    AF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br>Major Surgical or Invasive Procedure:<br>None.<br><br>History of Present Illness:<br>Mr. [**Known lastname 70654**] is a 75M with a history of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>s/p CABG x3 ([**University/College **] Presbyterian NY, [**2145**]), PTCA x2 stents<br>(DES: proximal LAD and SVG to PDA, [**2156**]) as well as<br>assymptomatic 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PAF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 who presented to [**Hospital1 18**] on [**2159-4-21**]<br>with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fatigue
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 for the last 5 days. He did not endorse shortness<br>of breath or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chest
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, only generalized 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fatigue
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Other ROS<br>were negative and notable for the absence of fevers, chills,<br>productive cough, sick contacts, recent travel or other<br>complaints.<br><br>In the ED, initial vitals: 97.8 65 132/78 16 97. CXR showed a<br>small new right pleural effusion. EKG showed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>at a rate of 114, and ST depression II, III, AVf, V4-V6. He was<br>given 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and placed on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Oxygen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Cardiac biomarkers were<br>negative x 3. He was loaded with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemical
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
<br>cardioversion of his a 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fib
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and went into NSR after the first<br>dose. The following morning he developed worsening dyspnea and<br>was found to be 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypoxic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with O2 sats in the 70s on RA. He<br>triggerred for hypoxia and was found to have 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    expiratory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    wheezes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>and crackles at the base. Chest x-ray showed severe 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>and opacities within both lower lobes. VBG showed pH 7.42, pO2<br>53, pCo2 30. He was placed on a non-rebreather with O2 sats that<br>returned to 92%. The team felt that his symptoms were either 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CHF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>versus 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, with CHF more likely because he did not have a<br>white count or fever at the time. He was diuresed with 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    20
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 x 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 and had 2 L of urine output. He remained on the<br>non-rebreather throughout the afternoon despite the diuresis. He<br>was given 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nebulizers
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and ordered 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    doxycycline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    augmentin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for<br>possible 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    community
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acquired
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 (although he did not<br>receive 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
). At 6:30 pm nightfloat came to evaluate the<br>patient and was concerned. An ABG showed pH 7.42 pO2 66 and pCO2<br>54. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vanc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cefipime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were started and the CCU was called to<br>evaluate the patient.<br><br>The patient was found to be 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tachypneic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    uncomfortable
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, using<br>increase work of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    breathing
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. He was sating 92% on the<br>non-rebreather. He was transferred for hypoxic respiratory<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    distress
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. In the CCU he endorsed chills, but denied fever, chest<br>pain, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    palpitations
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, cough, abdominal pain, HA, dysuria,<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    myalgias
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    melena
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br>Respiratory status continued to be tenuous in the CCU requiring<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    face
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mask
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    during
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
, and BiPap overnight. Patient was not<br>intubated due to concerns about ability to wean from the vent.<br>He was treated empirically with broad spectrum.<br><br>CCU course notable for increasing 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    respiratory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    distress
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 requiring<br>BiPap for comfort. Initially used overnight only with 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    face
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mask
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
<br>during the day but increasingly requiring 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BiPap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Was seen by his<br>outpatient pulmonologist who agreed with current plan, and felt<br>patient likely to be difficult to wean from the vent if<br>intubated. +6L LOS (not counting insensible losses). Admission<br>weight 53.1kg, currently weighs 56.1 kg(but unreliable as bed<br>weight with sheets etc). Patient had intermittent 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    A
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fib
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with<br>RVR requiring 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    boluses
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 of 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    control
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br><br>Past Medical History:<br>1. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>-CABG in [**2145**]: SVG to RPDA; SVG sequentially to diagonal and OM;<br>no LIMA graft<br>-Cath in [**2156**] notable for occlusion of a vein graft to the right<br>PDA treated with a 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DES
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and a subsequent elective native vessel<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LAD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PCI
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>2. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PAF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: rate controlled with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atenolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    warfarin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>3. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dyslipidemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>4. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>5. OSA on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BiPAP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 11cm insp and 9cm exp pressures<br>6. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tuberculosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 as a child, status post left upper lobe<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lobectomy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>7. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BPH
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>8. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    kyphoscoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>9. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sinususitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br><br>Social History:<br>- Married, Lives in [**Location 745**] with Wife, Three Children<br>- Holocaust survivor<br>- Retired child psychologist at [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] [**Location (un) **] in NY<br><br>- Tobacco history: Denies<br>- ETOH: Denies<br>- Illicit drugs: Denies<br><br><br>Family History:<br>No family history of early MI, arrhythmia, cardiomyopathies, or<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    sudden
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cardiac
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    death
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>- Father: Killed during Holocaust<br>- Mother: Died in 90s, no known medical history<br>- Sister: [**Name (NI) **] [**Name (NI) 3730**], 50s.<br><br><br>Physical Exam:<br>Gen: Pleasant. NAD. Oriented x3. Mood, affect appropriate.<br>HEENT: 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sclera
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    anicteric
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. PERRL, EOMI. Conjunctiva were pink, no<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pallor
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cyanosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    oral
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mucosa
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>Neck: Supple with full EJ and JVP slightly above clavicle<br>CV: normal S1, S2. No m/r/g.<br>Chest: 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sever
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Kyphoscoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Patient appeared uncomfortable<br>breathing, increased work, + accessory muscle use, + expiratory<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    wheezes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and decreased breath sounds on right and left bases. +<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    egophony
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and + 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fremitus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on right base.<br>Abd: Soft, NTND. No HSM or tenderness.<br>Ext: 1+ 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pedal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ankle
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 Bilaterally.<br>Skin: No stasis dermatitis, ulcers, scars, or xanthomas.<br><br><br>Pertinent Results:<br>Lab Data on Admission<br>[**2159-4-21**] 08:50AM BLOOD WBC-6.3 RBC-3.91* Hgb-12.2* Hct-36.9*<br>MCV-94 MCH-31.2 MCHC-33.0 RDW-15.0 Plt Ct-141*<br>[**2159-4-21**] 08:50AM BLOOD Neuts-67.3 Lymphs-24.0 Monos-5.5 Eos-2.6<br>Baso-0.6<br>[**2159-4-21**] 08:50AM BLOOD PT-28.1* PTT-37.9* INR(PT)-2.8*<br>[**2159-4-21**] 08:50AM BLOOD Glucose-120* 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    UreaN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-34* Creat-1.2 Na-142<br>K-4.3 Cl-102 HCO3-33* AnGap-11<br>[**2159-4-21**] 08:50AM BLOOD ALT-41* AST-36 LD(LDH)-211 CK(CPK)-70<br>AlkPhos-140* TotBili-0.4<br>[**2159-4-21**] 08:50AM BLOOD CK-MB-NotDone cTropnT-&lt;0.01 proBNP-3733*<br>[**2159-4-21**] 08:50AM BLOOD TSH-2.6<br><br>Pertinent Labs from During the Admission<br>[**2159-4-22**] 05:30AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-8.9 Phos-3.0 Mg-1.9<br>[**2159-4-23**] 03:43AM BLOOD VitB12-728 Folate-19.0<br>[**2159-4-23**] 03:43AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ASA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NEG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Acetmnp
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-10.0 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bnzodzp
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
NEG<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Barbitr
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NEG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tricycl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NEG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>[**2159-4-22**] 06:45PM BLOOD Lactate-1.2<br>[**2159-4-23**] 04:00AM BLOOD freeCa-1.13<br><br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Gas
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lactate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cardiac
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Enzymes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
<br>[**2159-4-21**] 08:50AM BLOOD CK-MB-NotDone cTropnT-&lt;0.01 proBNP-3733*<br>[**2159-4-21**] 08:50AM BLOOD cTropnT-&lt;0.01<br>[**2159-4-21**] 01:07PM BLOOD CK-MB-NotDone cTropnT-&lt;0.01<br>[**2159-4-21**] 09:18PM BLOOD CK-MB-NotDone cTropnT-&lt;0.01<br>[**2159-4-22**] 07:24PM BLOOD CK-MB-3 cTropnT-&lt;0.01<br>[**2159-4-23**] 03:43AM BLOOD CK-MB-3 cTropnT-&lt;0.01<br>[**2159-4-23**] 03:15PM BLOOD CK-MB-4 cTropnT-&lt;0.01<br>[**2159-4-24**] 03:57AM BLOOD CK-MB-3 cTropnT-&lt;0.01<br>[**2159-4-27**] 05:30AM BLOOD proBNP-4224*<br>[**2159-4-22**] 01:13PM BLOOD Type-[**Last Name (un) **] Temp-37.0 pO2-30* pCO2-53*<br>pH-7.37 calTCO2-32* Base XS-3<br>[**2159-4-22**] 06:45PM BLOOD Type-ART pO2-66* pCO2-34* pH-7.42<br>calTCO2-23 Base XS--1<br>[**2159-4-23**] 04:00AM BLOOD Type-[**Last Name (un) **] Temp-38.4 pO2-60* pCO2-59*<br>pH-7.40 calTCO2-38* Base XS-8 Intubat-NOT INTUBA<br>[**2159-4-23**] 05:19PM BLOOD Type-[**Last Name (un) **] Temp-36.3 Rates-/25 FiO2-80 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    O2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>Flow-12 pO2-42* pCO2-53* pH-7.40 calTCO2-34* Base XS-5 AADO2-495<br>REQ 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    O2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-81 Intubat-NOT INTUBA Comment-
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NEBULIZER
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>[**2159-4-24**] 02:14PM BLOOD Type-ART Temp-36.6 pO2-51* pCO2-42<br>pH-7.48* calTCO2-32* Base XS-6 Intubat-NOT INTUBA<br>[**2159-4-24**] 03:37PM BLOOD Type-ART Temp-36.6 Rates-/26 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    O2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 Flow-12<br>pO2-54* pCO2-43 pH-7.45 calTCO2-31* Base XS-4 Intubat-NOT INTUBA<br>Comment-
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NON
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    REBREA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>[**2159-4-26**] 05:03PM BLOOD Type-[**Last Name (un) **] pO2-30* pCO2-57* pH-7.33*<br>calTCO2-31* Base XS-1<br>[**2159-4-27**] 05:33AM BLOOD Type-[**Last Name (un) **] pO2-49* pCO2-57* pH-7.31*<br>calTCO2-30 Base XS-0<br>[**2159-4-22**] 06:45PM BLOOD Lactate-1.2<br>[**2159-4-23**] 04:00AM BLOOD Lactate-2.1*<br>[**2159-4-23**] 05:19PM BLOOD Lactate-1.4<br>[**2159-4-24**] 02:14PM BLOOD Lactate-1.6<br>[**2159-4-26**] 05:03PM BLOOD Lactate-0.9<br><br>Other Reports<br><br>EKG [**2159-4-21**]<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    with
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    premature
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ventricular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contractions
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    uncontrolled
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ventricular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    response
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Compared to tracing #2 the<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    heart
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 is faster.<br>Rate PR 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QRS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QT
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QTc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 P 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QRS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 T<br>114 0 104 330/424 0 16 -164<br><br>CXR [**2159-4-21**]<br>COMPARISON: Multiple prior chest radiographs from [**2157-1-5**],<br>[**2157-3-2**], and [**2159-1-17**]. CTA chest was performed on [**2157-3-10**].<br>CHEST RADIOGRAPH, PA AND LATERAL VIEWS: The patient is status<br>post median sternotomy, CABG, and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stenting
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    thoracolumbar
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    spine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, with deformity of<br>the left rib cage, again limits evaluation. Left lung volume is<br>chronically small. Left pleural thickening with calcification is<br>as before. On the right, there is small pleural 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    effusion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 which<br>is new since [**2159-1-17**]. There may be subtle ill-defined opacity<br>in the right lung base. No overt pulmonary 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 is seen.<br>Cardiac enlargement is unchanged.<br>IMPRESSIONS: Evaluation limited by spine and ribcage deformity.<br>New small right pleural effusion and subtle opacity in the right<br>lung 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    base
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, which could represent aspiration, atelectasis, and/or<br>developing consolidation.<br><br>Echo [**2159-4-23**]<br>  The left atrium is mildly dilated. No atrial septal defect is<br>seen by 2D or color Doppler. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Left
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ventricular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    wall
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    thicknesses
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>and cavity size are normal. There is mild regional left<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ventricular
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 systolic 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dysfunction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with infero-lateral<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypokinesis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. There is no ventricular septal defect. The right<br>ventricular cavity is mildly dilated with mild global free wall<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypokinesis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. The aortic valve leaflets (3) are mildly thickened<br>but aortic stenosis is not present. Trace aortic regurgitation<br>is seen. The mitral valve leaflets are mildly thickened. Mild to<br>moderate ([**1-13**]+) 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mitral
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    regurgitation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 is seen. The tricuspid<br>valve leaflets are mildly thickened. There is mild pulmonary<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 systolic 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. There is no pericardial effusion.<br>  Compared with the report of the prior study (images<br>unavailable for review) of [**2158-6-13**], no definite change.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CARDIAC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CATH
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 performed on [**2156-10-4**] demonstrated:<br>1. Coronary angiography in this right dominant system<br>demonstrated a normal LMCA with collaterals to RPL. The LAD had<br>a 90% proximal lesion with competitive flow. The LCX system had<br>an occluded<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    OM
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. The RCA was not selectively engaged.<br>2. Graft angiography showed a 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    patent
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SVG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 to diagonal and OM. The<br>SVG to RPDA had a 99% proximal stenosis.<br>3. Limited resting hemodynamics as detailed above revealed<br>mildly<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    elevated
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    filling
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pressures
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>4. PCI of SVG-RPDA with 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 X 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    28
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 mm Cypher DES and no residual<br>stenosis or complications (see PTCA comments for detail).<br>FINAL 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DIAGNOSIS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>1. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Three
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 vessel 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>2. Patent 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SVG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diagonal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
OM 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    graft
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>3. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Proximal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stenosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SVG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RCA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, successful PCI with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cypher
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>drug-eluting 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stent
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CARDIAC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CATH
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 performed on [**2156-10-6**] demonstrated:<br>1. Successful stenting 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    proximal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LAD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 X 13 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cypher
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>[**Name Prefix (Prefixes) **]<br>[**Last Name (Prefixes) 7930**] to 3.0 with no residual stenosis.<br>2. Distal LAD myocardial bridge with compression during systole<br>but<br>normal flow at diastole.<br>FINAL 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DIAGNOSIS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>1. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Two
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 vessel 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>2. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Successful
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stenting
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    proximal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LAD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cypher
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 DES.<br><br>CXR [**2159-4-22**]<br>IMPRESSIONS: FINDINGS: Comparison is made to prior study from<br>[**2159-4-21**]. Study is markedly limited due to patient<br>positioning and the 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Allowing for this,<br>however, there appears to be opacities within both lower lobes<br>which are worrisome for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    consolidation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. The<br>consolidations on the right side are much more apparent than on<br>the study from yesterday. Aspiration cannot be excluded.<br><br>CXR [**2159-4-27**]<br>FINDINGS: As compared to the previous radiograph, the volume of<br>the right hemithorax has decreased. As a consequence, there is<br>increased crowding 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    right
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 perihilar vessels. However,<br>there is no clear evidence of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 (the film strongly<br>resembles the examination performed on [**2159-4-24**], 8:03<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    m
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
.). Unchanged marked asymmetry of the chest wall given the<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    extreme
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Unchanged size of the cardiac silhouette.<br><br>CT chest [**2159-4-28**]<br>1. Moderate right 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pleural
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 effusion with adjacent<br>telectasis/consolidation.<br>2. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Scattered
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ground
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    glass
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    opacities
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    enlarged
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    heart
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. These<br>findings are most likely representative of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pulmonary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>3. Calcified left pleural plaques consistent 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    empyema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>4. Prominent abdominal vessels are limited due to lack of<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    intravenous
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 but suggestive of varices. Clinical correlation is<br>recommended.<br>5. Marked thoracic 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cage
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 distortion due to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br>Pleural 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 [**2159-4-29**]<br>NEGATIVE FOR 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    MALIGNANT
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CELLS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br>CXR [**2159-5-10**]<br>As compared to the previous radiograph, the lung volumes are<br>unchanged. Presence of a minimal right-sided pleural effusion<br>cannot be<br>excluded. Minimally increased diameters of the pulmonary vessels<br>in the right upper lobe could indicate mild 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    overhydration
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Unchanged size of the cardiac silhouette. Unchanged aspect of<br>the left lung.<br><br>DISCHARGE LABS:<br>[**2159-5-15**] WBC-7.7 RBC-3.72* Hgb-11.2* Hct-35.0* MCV-94 Plt Ct-335<br>[**2159-5-15**] PT-29.5* PTT-37.2* INR(PT)-2.9*<br>[**2159-5-15**] Glucose-94 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    UreaN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-44* Creat-1.2 Na-142 K-4.1 Cl-96<br>HCO3-38* [**2159-5-15**] 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-9.3 Phos-3.8 Mg-2.1<br><br>Brief Hospital Course:<br>Brief Hospital Course<br>Professor [**Known lastname 70654**] is a 75 YOM with paroxysmal atrial<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 who presented with 5<br>days of fatigue and was found to be in 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillaton
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RVR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. Patient was admitted to the cardiology service and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was initiated given 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. On HD#1<br>patient develope hypoxic respiratory distress reguiring transfer<br>to the CCU where he was treated for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    community
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acquired
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Doxycycline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 given concern for QT<br>prolongatoin. During his stay in the CCU he was intermittently<br>in 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    with
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RVR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 and would intermittently develop<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    respiratory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    distress
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 reguiring BiPap.  Patient was eventually<br>transferred to the MICU for more intensive management of his<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pulmonary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    issues
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. There the patient completed his course of<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and was diuresed. Slowly the patients breathing<br>improved and on [**5-4**] was transfered to the general medical<br>floor.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypoxic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 Respiratory 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Distress
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>On presentation to the hospital patient was at baseline<br>pulmonary status. Initial CXR with question of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RLL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    opacity
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. On<br>HD#1 patient developed hypoxic respiratory failure which<br>[**Hospital 70655**] transfer to the CCU and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    broad
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 spectrum 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to<br>treat 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RLL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 visualized on CXR. Further patient became<br>febrile prior to transfer. Initially patient was thought to have<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RLL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 infiltrate c/w 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    high
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fever
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Patient was treated<br>for probable 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RLL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Doxycycline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 completing an 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    8
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
 course. On transfer to the MICU<br>the patient appeared to have superimposed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pulmonary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 from<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    volume
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    resuscitation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 as evidenced by LOS fluid balance, interval<br>weight, and clinical exam.  MICU attempted low dose 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>overnight [**4-27**] for diuresis and monitored respiratory status,<br>with 700cc out and no worsening in creatinine.  Non-
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contrast
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 CT<br>showed moderate right sided 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pleural
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    effusion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Based upon<br>patient's 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    respiratory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    distress
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, he underwent a 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5L
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
<br>thoracentesis on [**4-29**] with interval improvement in respiratory<br>status. Patient has limited reserve given prior pneumonectomy<br>and severe 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    kyphoscoliosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and may not tolerate small volumes of<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. A Urine legionella was negative. Blood cultures negative<br>(finalized). Sputum cultures contaminated. Pleural fluid<br>appeared transudative and cultures NGTD. The patient was<br>maintained on 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nebulizers
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
. The patient underwent<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aggressive
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and was negative<br>approximately 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    liters
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 for his MICU stay (though even from<br>admission weight). The patient initially required BiPap around<br>the clock.  He was weaned to a shovel mask and eventually to a<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nasal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cannula
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  He continued on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BiPap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 at 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    night
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>with his home settings. Based upon radiographic images, there<br>was concern that patient may be aspirating.  He was evaluated by<br>speech and swallow who cleared the patient for solids and thin<br>liquids; 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pills
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 whole with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    puree
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
. After diuresis patient<br>continued to improve, no longer needing 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BiPAP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 during the day.<br>Patient was transferred to the general medical floor where<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 was continued. The patient was maintained on 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nasal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cannula
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2L
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    for
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    week
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
, and finally weaned down to RA, satting<br>mid90s on discharge. The patient was discharged on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aldactone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>On admission to the hospital patient was found to be in atrial<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. With therapeutic INRs for the past two months.<br>Decision was made to start 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Patient initially<br>converted to sinus rhythm prior to transfer to CCU. During CCU<br>stay patient was paroxysmally in 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 which was<br>intermittently controlled with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  The patient was<br>continued on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 per EP recommendations, and daily EKGs<br>were initially obtained to monitor for QT prolongation.  The<br>patient's 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was up-titrated as tolerated.  At the time<br>of leaving the MICU, he was on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Extended
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    240mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
.  He was in sinus 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rhythm
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. On the floor, the patient was<br>intermittently in 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    afib
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. He was started on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>for better 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    heart
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    control
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. He was intermittently in 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    afib
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    junction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rhythm
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 (rate 60s-80s). 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was discontinued on<br>[**5-14**]. He was discharged on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dilt
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    240mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metabolic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    alkalosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>Thought to be secondary to aggressive 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    contraction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    alkalosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
). Correction may help respiratory status<br>by preventing 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    compensatory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypoventilation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. On his last day in<br>the MICU, he was started on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acetazolamide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    250
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 [**Hospital1 **].<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Junctional
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bradycardia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>Likely secondary to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    beta
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    blockers
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  The patient was started on<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, as recommended by EP. The patient was noted to be in<br>a junctional rhythm, but was not bradycardic.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Coronary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    artery
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
:<br>post CABG and [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **] 2.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ST
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    depressions
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 on EKG (stable, but<br>worsened with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tachycardia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 150s).  No active chest pain.<br>Cardiac enzymes negative. The patient was continued on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    81
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 and his home dose 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lipitor
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypernatremia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
:<br>The patient was intermittently 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypernatremic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 while in the MICU,<br>most recently with Na 146 on [**5-4**] free water deficit of 1.4L. He<br>intermittently received 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D5W
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 X 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1000
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 and PO intake was<br>encouraged.<br><br>OSA: Continued Home 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BiPAP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hyperlipidemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Continued 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atorvastatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br><br>Medications on Admission:<br> (per DC Summary [**2159-1-18**])<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atenolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atorvastatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    20
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fluticasone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mcg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nasal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Spray
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lorazepam
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablets
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    anxiety
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    insomnia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Mirtazapine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    7
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nifedipine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    60
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nitroglycerin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chest
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Risedronate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    35
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    weekly
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>9. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Warfarin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>10. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>11. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Os
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    +
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    250mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    400
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
, 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>12. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rhamnosus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>13. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bipap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br><br>Discharge Medications:<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atorvastatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    20
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
).<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fluticasone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mcg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Actuation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Spray
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Suspension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 (1)<br>
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Spray
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nasal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lactobacillus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rhamnosus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    billion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cell
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: One<br>(1) 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    constipation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    81
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chewable
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chewable
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Mirtazapine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    15
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Two
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (at<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bedtime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Insomnia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    anxiety
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Disp:*60 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HCl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    120
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sustained
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: Two (2)<br>
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sustained
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (2 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    times
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>Disp:*120 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Capsule
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sustained
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    s
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
* Refills:*0*<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tartrate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    times
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>Disp:*60 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Warfarin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2X
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    WEEK
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>([**Doctor First Name **],TU).<br>9. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Warfarin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4X
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    WEEK
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(MO,WE,TH,FR,SA).<br>10
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Os
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    +
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    D
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    250mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    400
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 (1)<br>
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>11. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Miconazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nitrate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Powder
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Appl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Topical
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 [**Hospital1 **]<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    times
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    for
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    days
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
.<br>Disp:*1 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    container
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
* Refills:*0*<br>12. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    20
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>Disp:*30 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>13. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aldactone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    :
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>Disp:*15 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br><br><br>Discharge Disposition:<br>Home With Service<br><br>Facility:<br>[**Hospital 119**] Homecare<br><br>Discharge Diagnosis:<br>Primary:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diastolic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Heart
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Failure
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Paroxysmal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 [**Hospital 9343**]<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Health
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 care Associated 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Restrictive
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pulmonary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 secondary to kyphoscoliosis<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CAD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HTN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HLD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br><br>Discharge Condition:<br>Mental Status: Clear and coherent.<br>Level of Consciousness: Alert and interactive.<br>Activity Status: Ambulatory - Independent.<br><br><br>Discharge Instructions:<br>Dear Mr. [**Known lastname 70654**],<br>.<br>It was a pleasure caring for you while you were hospitalized<br>with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fatigue
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    shortness
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    of
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    breath
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. During your stay your<br>breathing became extremely 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    labored
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 [**Hospital 70656**] transfer to the<br>Intensive Care Unit were you were treated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. While in the ICU your breathing was slow to improve<br>so you were also 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuresed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diuretics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
). Slowly your<br>breathing improved and you were transfered to regular medical<br>floor. Throughout this time your heart rate was in and out of<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Electrophysiology recommended 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    good
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    control
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. You were also on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dofetilide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>which was stopped since it did not keep you in a normal heart<br>rhythm.<br>.<br>Please take all your medications as prescribed and keep all of<br>your follow up appointments. Weigh yourself 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    morning
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
, and<br>call your physician if your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    weight
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    goes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    up
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    more
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    than
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lbs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. You<br>should also have lab work checked at your visit on [**2159-5-18**] to<br>ensure your kidney function and electrolytes are normal.<br>.<br>The following changes were made to your medication regimen:<br>#. CHANGE 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atenolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metoprolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    by
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mouth
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>#. STOP 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Nifedipine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>#. START 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diltiazem
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    240mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    by
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mouth
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>#. START 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Miconazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    powder
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for you groin<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
<br>#. Start 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    20mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 on [**2159-5-17**] (Call PCP and stop if you<br>feel 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lightheaded
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dizzy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
)<br>#. Start 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aldactone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    12
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 on [**2159-5-17**] )Call PCP and stop if<br>you feel 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lightheaded
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dizzy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
)<br>#. We also increased your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mirtazapine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    30mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    at
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nighttime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>#. DECREASE your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    81
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br><br>Followup Instructions:<br>PCP: [**Name10 (NameIs) **] have been set up to see a Nurse Practitioner, as well<br>as your primary care physician in the next week:<br>Provider: [**Name10 (NameIs) **] 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FERN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, RNC<br>Phone:[**Telephone/Fax (1) 250**]<br>Date/Time:[**2159-5-18**] 9:00<br>.<br>Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 7212**], MD<br>Phone:[**Telephone/Fax (1) 250**]<br>Date/Time:[**2159-5-25**] 10:30<br>.<br>Cardiology: Please follow-up with Dr. [**Last Name (STitle) **]<br>Date/Time: [**6-15**] at 2pm<br>Phone: [**Telephone/Fax (1) 62**]<br>.<br>Other Appointments:<br>ORTHO 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    XRAY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 (SCC 2)<br>Phone:[**Telephone/Fax (1) 1228**]<br>Date/Time:[**2159-6-14**] 10:40<br>.<br>DR. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) **] (ortho spine)<br>Phone:[**Telephone/Fax (1) 3736**]<br>Date/Time:[**2159-6-14**] 11:00<br>.<br>PULMONARY FUNCTION LAB<br>Phone:[**Telephone/Fax (1) 609**]<br>Date/Time:[**2159-6-15**] 11:10<br>.<br>DR. [**Last Name (STitle) **]<br>Phone: [**Telephone/Fax (1) 612**]<br>Date/Time:[**2159-6-15**] 11:30<br><br><br>                             [**Name6 (MD) **] [**Name8 (MD) **] MD, [**MD Number(3) 2073**]<br><br></div>